Back to search

American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010

Data up to Jan 2025

Published2010
Citations926
References147
Clinical Trials (1)

Total Citations Per Year

Abstract

References (147)

Screening and Prostate-Cancer Mortality in a Randomized European Study

2009 • 3,866 citations

Mortality Results from a Randomized Prostate-Cancer Screening Trial

2009 • 2,828 citations

Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate

1987 • 2,447 citations

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

2012 • 2,379 citations

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1991 • 2,353 citations

Developing a quality criteria framework for patient decision aids: online international Delphi consensus process

2006 • 1,629 citations

20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer

2005 • 1,179 citations

Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update

2007 • 1,116 citations

Longitudinal Evaluation of Prostate-Specific Antigen Levels in Men With and Without Prostate Disease

1992 • 1,065 citations

Cancer Screening in Elderly Patients

2001 • 987 citations

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

2002 • 930 citations

Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

2006 • 898 citations

American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001--Testing for Early Lung Cancer Detection

2001 • 849 citations

Comparative Effectiveness of Minimally Invasive vs Open Radical Prostatectomy

2009 • 819 citations

Prostate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific Antigen

1990 • 767 citations

Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context

2009 • 744 citations

Quality of Life after Radical Prostatectomy or Watchful Waiting

2002 • 727 citations

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer

2008 • 704 citations

Pamidronate to Prevent Bone Loss during Androgen-Deprivation Therapy for Prostate Cancer

2001 • 703 citations

Prostate Cancer Detection in Men With Serum PSA Concentrations of 2.6 to 4.0 ng/mL and Benign Prostate Examination

1997 • 675 citations

Five-Year Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: The Prostate Cancer Outcomes Study

2004 • 663 citations

Cancer Surveillance Series: Interpreting Trends in Prostate Cancer Part I: Evidence of the Effects of Screening in Recent Prostate Cancer Incidence, Mortality, and Survival Rates

1999 • 662 citations

Development and Validation of a Prognostic Index for 1-Year Mortality in Older Adults After Hospitalization

2001 • 626 citations

Rethinking Screening for Breast Cancer and Prostate Cancer

2009 • 516 citations

Prostate Specific Antigen Best Practice Statement: 2009 Update

2009 • 507 citations

Pelvic Lymph Node Dissection in Prostate Cancer

2009 • 474 citations

Outcomes of Localized Prostate Cancer Following Conservative Management

2009 • 432 citations

Shared decision making about screening and chemoprevention

2003 • 405 citations

Screening Men for Prostate and Colorectal Cancer in the United States

2003 • 369 citations

Feasibility Study: Watchful Waiting For Localized Low To Intermediate Grade Prostate Carcinoma With Selective Delayed Intervention Based On Prostate Specific Antigen, Histological And/Or Clinical Progression

2002 • 346 citations

Evaluation of the Digital Rectal Examination as a Screening Test for Prostate Cancer

1998 • 341 citations

Basic Issues in Population Screening for Cancer<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>

1980 • 329 citations

Expectant Management of Prostate Cancer With Curative Intent: An Update of The Johns Hopkins Experience

2007 • 327 citations

Promoting informed decisions about cancer screening in communities and healthcare systems

2003 • 326 citations

Shared Decision Making in Health Care

2016 • 323 citations

OPTIMAL PREDICTORS OF PROSTATE CANCER ON REPEAT PROSTATE BIOPSY: A PROSPECTIVE STUDY OF 1,051 MEN

2000 • 321 citations

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria

2001 • 320 citations

Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers

1993 • 309 citations

Detection of Life-Threatening Prostate Cancer With Prostate-Specific Antigen Velocity During a Window of Curability

2006 • 306 citations

INTRAOPERATIVE AND POSTOPERATIVE COMPLICATIONS OF RADICAL RETROPUBIC PROSTATECTOMY IN A CONSECUTIVE SERIES OF 1,000 CASES

2001 • 306 citations

Defining sexual outcomes after treatment for localized prostate carcinoma

2002 • 305 citations

Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: A strategy for large-scale implementation for the treatment of carcinoma of the prostate

1997 • 302 citations

Incidence of Urethral Stricture After Primary Treatment for Prostate Cancer: Data From CaPSURE

2007 • 301 citations

Hormonal Therapy Use for Prostate Cancer and Mortality in Men With Coronary Artery Disease–Induced Congestive Heart Failure or Myocardial Infarction

2009 • 279 citations

Prostate-cancer mortality in the USA and UK in 1975–2004: an ecological study

2008 • 273 citations

PSA Screening Among Elderly Men With Limited Life Expectancies

2006 • 258 citations

One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men

2004 • 255 citations

Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer

2008 • 254 citations

Systematic Review of Pretreatment Prostate-Specific Antigen Velocity and Doubling Time As Predictors for Prostate Cancer

2008 • 252 citations

Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings From the Initial Screening Round of a Randomized Trial

2005 • 235 citations

Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut

2002 • 223 citations

Interexaminer variability of digital rectal examination in detecting prostate cancer

1995 • 222 citations

Anxiety and distress during active surveillance for early prostate cancer

2009 • 219 citations

Screening decreases prostate cancer mortality: 11‐year follow‐up of the 1988 Quebec prospective randomized controlled trial

2004 • 217 citations

PRACTICE OF UROLOGY

1922 • 216 citations

Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

2009 • 211 citations

Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less

2006 • 209 citations

Interpreting Trends in Prostate Cancer Incidence and Mortality in the Five Nordic Countries

2007 • 200 citations

International trends in prostate-cancer mortality in the ?PSA era?

2001 • 189 citations

Short-Term Effects of Population-Based Screening for Prostate Cancer on Health-Related Quality of Life

1998 • 177 citations

High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey.

2002 • 170 citations

Recommended Prostate-Specific Antigen Testing Intervals for the Detection of Curable Prostate Cancer

1997 • 163 citations

Active Surveillance for Prostate Cancers Detected in Three Subsequent Rounds of a Screening Trial: Characteristics, PSA Doubling Times, and Outcome

2006 • 160 citations

Trials of Decision Aids for Prostate Cancer Screening

2007 • 160 citations

Comparative Efficiency of Prostate-Specific Antigen Screening Strategies for Prostate Cancer Detection

2000 • 158 citations

Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial

2008 • 155 citations

Familial prostate cancer in sweden: A nationwide register cohort study

1996 • 155 citations

Cancer Screening in Theory and in Practice

2005 • 152 citations

Survivorship Beyond Convalescence: 48-Month Quality-of-Life Outcomes After Treatment for Localized Prostate Cancer

2009 • 147 citations

Prostate Cancer Screening Decisions

2009 • 139 citations

THE INCIDENCE OF PROSTATE CANCER IN A SCREENING POPULATION WITH A SERUM PROSTATE SPECIFIC ANTIGEN BETWEEN 2.5 AND 4.0 NG./ML.: RELATION TO BIOPSY STRATEGY

2001 • 139 citations

The Role of the Digital Rectal Examination in Subsequent Screening Visits in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam

2008 • 133 citations

Implications of Stage-Specific Survival Rates in Assessing Recent Declines in Prostate Cancer Mortality Rates

2000 • 133 citations

Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality

2008 • 126 citations

Asymptomatic Incidence and Duration of Prostate Cancer

1998 • 126 citations

Entertainment education for prostate cancer screening: A randomized trial among primary care patients with low health literacy

2008 • 125 citations

Case-control study of screening for prostatic cancer by digital rectal examinations

1991 • 122 citations

Estimating Lead Time and Overdiagnosis Associated with PSA Screening from Prostate Cancer Incidence Trends

2007 • 121 citations

Androgen Deprivation Therapy, Insulin Resistance, and Cardiovascular Mortality: An Inconvenient Truth

2008 • 115 citations

HEALTH RELATED QUALITY OF LIFE IN OLDER MEN WITHOUT PROSTATE CANCER

1999 • 115 citations

Does active surveillance for men with localized prostate cancer carry psychological morbidity?

2007 • 114 citations

Predicting Prostate Cancer Risk Through Incorporation of Prostate Cancer Gene 3

2008 • 114 citations

Predictors of Prostate Cancer After Initial Negative Systematic 12 Core Biopsy

2004 • 111 citations

The Effectiveness of Screening for Prostate Cancer

2006 • 110 citations

Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands)

2003 • 106 citations

From IMRT to IGRT: Frontierland or Neverland?

2006 • 103 citations

Time, Symptom Burden, Androgen Deprivation, and Self-Assessed Quality of Life after Radical Prostatectomy or Watchful Waiting: The Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) Clinical Trial

2008 • 103 citations

Clinical Consequences of Screening for Prostate Cancer: 15 Years Follow-up of a Randomised Controlled Trial in Sweden

2004 • 102 citations

Long-Term Prediction of Prostate Cancer: Prostate-Specific Antigen (PSA) Velocity Is Predictive but Does Not Improve the Predictive Accuracy of a Single PSA Measurement 15 Years or More Before Cancer Diagnosis in a Large, Representative, Unscreened Population

2008 • 101 citations

1873: External Validation of the Prostate Cancer Prevention Trial Risk Calculator in a Screened Population

2007 • 101 citations

Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result

2004 • 97 citations

Physician–patient discussions of controversial cancer screening tests11The full text of this article is available via AJPM Online at www.elsevier.com/locate/ajpmonline.

2001 • 97 citations

The effect of study arm on prostate cancer treatment in the large screening trial ERSPC

2009 • 94 citations

The American Cancer Society Guidelines for the cancer-related checkup: an update

1991 • 92 citations

Application of the Case-Control Method in the Evaluation of Screening

1994 • 92 citations

American Cancer Society guideline for the early detection of prostate cancer: update 1997

1997 • 90 citations

Psychological reactions in men screened for prostate cancer

1995 • 89 citations

Screening for Prostate Cancer in High Risk Populations

2002 • 89 citations

Single Dose Levofloxacin Prophylaxis for Prostate Biopsy in Patients at Low Risk

2002 • 79 citations

The impact of a suspicious prostate biopsy on patients’ psychological, socio-behavioral, and medical care outcomes

2006 • 78 citations

Prospective study of depression and fatigue in men with advanced prostate cancer receiving hormone therapy

2007 • 77 citations

Prostate-Specific Antigen Velocity for Early Detection of Prostate Cancer: Result from a Large, Representative, Population-based Cohort

2009 • 75 citations

Complications occurring from diagnostic venipuncture.

1992 • 72 citations

Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) – Results from a prospective, population-based, randomised study

2007 • 71 citations

Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer

2008 • 68 citations

Screening digital rectal examination and prostate cancer mortality: a population-based case-control study

1998 • 64 citations

Prospective assessment of the efficacy of single dose versus traditional 3‐day antimicrobial prophylaxis in 12‐core transrectal prostate biopsy

2008 • 60 citations

A clinical method for real-time dosimetric guidance of transperineal 125i prostate implants using interventional magnetic resonance imaging

2000 • 59 citations

Calibrating disease progression models using population data: a critical precursor to policy development in cancer control

2010 • 55 citations

Outbreak of Pseudomonas aeruginosa Infections After Transrectal Ultrasound-Guided Prostate Biopsy

2007 • 55 citations

SERIAL PROSTATE SPECIFIC ANTIGEN SCREENING FOR PROSTATE CANCER: A COMPUTER MODEL EVALUATES COMPETING STRATEGIES

1999 • 53 citations

INCIDENCE AND MANAGEMENT OF GYNECOMASTIA IN MEN TREATED FOR PROSTATE CANCER

2005 • 53 citations

Validation in a Multiple Urology Practice Cohort of the Prostate Cancer Prevention Trial Calculator for Predicting Prostate Cancer Detection

2009 • 53 citations

Measuring the psychosocial impact of population‐based prostate‐specific antigen testing for prostate cancer in the UK

2006 • 50 citations

Population‐based screening for prostate cancer by measuring free and total serum prostate‐specific antigen in Sweden

2003 • 48 citations

Impact of undergoing prostate carcinoma screening on prostate carcinoma‐related knowledge and distress

2002 • 48 citations

Complications and risk factors of transrectal ultrasound guided needle biopsies of the prostate evaluated by questionnaire

2008 • 47 citations

Family History and Prostate Cancer Screening With Prostate-Specific Antigen

2002 • 46 citations

Investigation of Design and Bias Issues in Case-Control Studies of Cancer Screening Using Microsimulation

2000 • 43 citations

One preoperative dose randomized against 3‐day antibiotic prophylaxis for transrectal ultrasonography‐guided prostate biopsy

2008 • 43 citations

Trends and risk factors for prostate biopsy complications in the pre-PSA and PSA eras, 1980 to 1997

2002 • 41 citations

Screening, Treatment, and Prostate Cancer Mortality in the Seattle Area and Connecticut: Fifteen-year Follow-up

2008 • 41 citations

An Ecologic Study of Prostate-specific Antigen Screening and Prostate Cancer Mortality in Nine Geographic Areas of the United States

2004 • 39 citations

The prognostic value of hemoglobin change after initiating androgen‐deprivation therapy for newly diagnosed metastatic prostate cancer

2006 • 38 citations

Screening by Prostate-Specific Antigen and Digital Rectal Examination in Relation to Prostate Cancer Mortality

2005 • 37 citations

Screening for prostate cancer without digital rectal examination and transrectal ultrasound: Results after four years in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam

2005 • 35 citations

Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial

2007 • 34 citations

Population‐based screening for prostate cancer by measuring total serum prostate‐specific antigen in Iran

2007 • 33 citations

LUTEINIZING HORMONE-RELEASING HORMONE AGONIST EFFECTS ON SKELETAL MUSCLE: HOW HORMONAL THERAPY IN PROSTATE CANCER AFFECTS MUSCULAR STRENGTH

2005 • 32 citations

Cognitive impairment in men treated with luteinizing hormone–releasing hormone agonists for prostate cancer: a controlled comparison

2009 • 32 citations

Prostate Cancer Risk Assessment Program: A 10-Year Update of Cancer Detection

2007 • 32 citations

Prostate Specific Antigen Changes as Related to the Initial Prostate Specific Antigen: Data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

2006 • 31 citations

Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

2005 • 31 citations

Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men

2007 • 29 citations

Test sensitivity of prostate‐specific antigen in the Finnish randomised prostate cancer screening trial

2004 • 28 citations

Men's attitudes toward prostate cancer and seeking prostate-specific antigen testing.

2001 • 27 citations

Population-Based Case-Control Study of PSA and DRE Screening on Prostate Cancer Mortality

2007 • 27 citations

Development and validation of risk score for predicting positive repeat prostate biopsy in patients with a previous negative biopsy in a UK population

2009 • 26 citations

Yearly Prostate Specific Antigen and Digital Rectal Examination Fluctuations in a Screened Population

2009 • 23 citations

Features and preliminary results of prostate cancer screening in Canton Aargau, Switzerland

2003 • 18 citations

Preoperative predictors of blood loss at the time of radical prostatectomy: results from the SEARCH database

2009 • 18 citations

Receiver operating characteristics of the prostate specific antigen test in an unselected population

2006 • 14 citations

E. coliMultiresistant Meningitis after Transrectal Prostate Biopsy

2006 • 6 citations

Digital rectal examination as a prostate cancer-screening method in a country with a low incidence of prostate cancer

2007 • 5 citations

THE EARLY DIAGNOSIS AND RADICAL CURE OF CARCINOMA OF THE PROSTATE.A STUDY OF FIFTY CASES AND PRESENTATION OF A RADICAL OPERATION.

1906 • 5 citations

Health-related quality-of-life effects of watchful waiting re-evaluated in SPCG-4

2009 • 3 citations

SECONDARY ANALYSIS OF THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC) - EFFECT OF PROSTATE CANCER SCREENING ON THE DEVELOPMENT OF METASTASES AFTER ADJUSTMENT FOR NON-COMPLIANCE AND CONTAMINATION

2009 • 2 citations

Cited By (0)

No citing papers found in database

American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010 (2010) – CA A Cancer Journal for Clinicians | Metascience Observatory Explorer